SCHEMBL5497597

SCHEMBL5497597

C[C@H](N)C(=O)Oc1ccccc1NC(=N)N

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
MAPT P10636 3/20 0.40
HSD17B10 Q99714 2/20 0.40
GAA P10253 1/20 0.40
HTT P42858 1/20 0.40
L3MBTL1 Q9Y468 4/20 0.40
KMT2A Q03164 3/20 0.40
KDM4E B2RXH2 1/20 0.40
LMNA P02545 3/20 0.39
POLB P06746 1/20 0.39
MEN1 O00255 1/20 0.39
RAB9A P51151 2/20 0.38
LPAR1 Q92633 1/20 0.38
MCL1 Q07820 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NPC1 O15118 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24260209 0.90 ALDH1A1 (0.43) ALDH1A1MAPTHSD17B10GAAHTT
SCHEMBL24260208 0.81 HSD17B10 (0.48) ALDH1A1MAPTHSD17B10GAAHTT
SCHEMBL7248994 0.77 NPC1 (0.59) MAPTL3MBTL1KMT2APOLBRAB9A
Acetic Acid SCHEMBL19639566 0.77 IRAK4 (0.50) ALDH1A1MAPTGAAHTTL3MBTL1
Oxalic Acid SCHEMBL19639579 0.77 IRAK4 (0.50) ALDH1A1MAPTGAAHTTL3MBTL1
SCHEMBL19639526 0.76 IRAK4 (0.49) ALDH1A1MAPTGAAHTTL3MBTL1
SCHEMBL7235274 0.76 KDM4E (0.54) ALDH1A1MAPTGAAHTTKMT2A
SCHEMBL3199566 0.76 KMT2A (0.51) ALDH1A1MAPTHTTL3MBTL1KMT2A
SCHEMBL7976424 0.76 KMT2A (0.51) ALDH1A1MAPTHTTL3MBTL1KMT2A
SCHEMBL237660 0.76 GLA (0.47) ALDH1A1MAPTGAAKMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1409547-A4 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR IMMUNE DECEPTION, PARTICULARLY USEFUL IN THE TREATMENT OF CANCER TECHNION RES AND DEV OF FOUNDA (IL) 2007-05-02 EP disclosed
EP-1682576-A1 VARIANTS OF HUMAN GLYCOPROTEIN HORMONE ALPHA CHAIN: COMPOSITIONS AND USES THEREOF Compugen Ltd. (IL) 2006-07-26 EP disclosed
EP-1660628-A2 SPLICE VARIANTS OF ErbB LIGANDS, COMPOSITIONS AND USES THEREOF Agos Biotech Ltd. (IL) 2006-05-31 EP disclosed
WO-2005044851-A1 VARIANTS OF HUMAN GLYCOPROTEIN HORMONE ALPHA CHAIN: COMPOSITIONS AND USES THEREOF COMPUGEN LTD. (IL) 2005-05-19 WO disclosed
WO-2005019259-A2 VARIANTS OF INTERLEUKIN-1 RECEPTOR ANTAGONIST: COMPOSITIONS AND USES THEREOF COMPUGEN LTD. (IL) 2005-03-03 WO disclosed
WO-2005017096-A2 SPLICE VARIANTS OF ErbB LIGANDS, COMPOSITIONS AND USES THEREOF AGOS BIOTECH LTD. (IL) 2005-02-24 WO disclosed
EP-1409547-A2 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR IMMUNE DECEPTION, PARTICULARLY USEFUL IN THE TREATMENT OF CANCER Technion Research and Development of Foundation, Ltd. (IL) 2004-04-21 EP disclosed
EP-1351992-A2 HYBRID PEPTIDES FOR TREATMENT OF BACTEREMIA AND SEPTICEMIA Ramot at Tel Aviv University Ltd. (IL) 2003-10-15 EP disclosed
WO-2002102299-A2 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR IMMUNE DECEPTION, PARTICULARLY USEFUL IN THE TREATMENT OF CANCER TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. (IL) 2002-12-27 WO disclosed
WO-2002055543-A2 HYBRID PEPTIDES FOR TREATMENT OF BACTEREMIA AND SEPTICEMIA UNIV RAMOT (IL) 2002-07-18 WO disclosed
WO-2000066707-A2 NOVEL THIAMINE TRANSPORTER, A POLYNUCLEOTIDE ENCODING SAME AND THEIR USES TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. (IL) 2000-11-09 WO disclosed